Brief: Island Pharmaceuticals Entered New One-Off Purchase Agreement With Curia, Inc
20/09/2021 02:53
Sept 20 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* ENTERED NEW ONE-OFF PURCHASE AGREEMENT WITH CURIA, INC TO
MANUFACTURE TWO 2.5 KILOGRAM DE NOVO BATCHES OF GMP DRUG
SUBSTANCE
* EXPECTS MANUFACTURING CAMPAIGN SHOULD RESULT IN SHORT
DELAY TO
EARLY Q1 2022 TO BEGIN TRIAL ENROLMENT
Source text for Eikon: ID:nASX9c5Q9z
Further company coverage: ILA.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic